PET i neuroscience nu och i framtiden

PET i neuroscience – nu och i framtiden Lars Farde Professor of Psychiatry, Karolinska Institutet Chief scientist, AstraZeneca TSC at KI Nuklearmedi...
Author: Carmel Brown
4 downloads 1 Views 3MB Size
PET i neuroscience – nu och i framtiden

Lars Farde Professor of Psychiatry, Karolinska Institutet Chief scientist, AstraZeneca TSC at KI

Nuklearmedicinens dag, Malmö, 2014-09-17

PET- publications in MedLine (2010) Oncology (total 2765 publ.)

Number of publications

Neurology+psychiatry (total 3900 publ.)

Immunology (total 1347 publ.) Respiratory (total 724 publ.) Neurosurgery (total 998 publ.) Cardiology (total 576 publ.) Hematology (total 322 publ.)

MedLine search ”positron emission tomography” AND ”[organ]” Kidney 1.72% Brain 31.13%

Lung 9.33% Cancer 37.10%

March 2013

As of today: Major applications of molecular imaging in drug discovery and development.   

Microdosing Drug occupancy at target of interest Biomarkers of pathophysiology

Microdosing - Brain exposure is critical for CNS-drugs • Low brain exposure - a significant reason for failure • Taylor E.M. (2002) Clin. Pharmacokinet. 41:81-92.

• Can be controled for by PET-microdosing • Injection IV of less than 1 microgram of labeled drug

• Primate study • CNS drug (mGluR5) • High brain exposure

• Primate study • Drug for a peripheral target (CB1) • Low brain exposure

Whole body PET-imaging 60 minutes after oral administration of an F-18 labeled drug.

High

Low

….two hours later

High

Low

Major applications of molecular imaging in drug discovery and development.   

Microdosing Drug occupancy at target of interest Biomarkers of pathophysiology

11C]raclopride binding to D2-dopamine receptors

Control

Haloperidol, 4 mg/d

Raclopride is an original synthesis from former Astra in Södertälje

Farde et al, 1986

Suggested thresholds for antipsychotic effect and extrapyramidal side-effects (EPS)

D2 receptor occupancy (%)

100 80

EPS Antipsychotic effect

60 40 20 0 0

4 Dose; plasma concentration

8

Farde et al, Arch Gen Psych,1992, ”citation classique”

Drug target occupancy A measurable link between pharmacokinetics and pharmacodynamics

Simon Cervenka

18/09/2014

12

11C]raclopride binding to D2-dopamine receptors

Control

Haloperidol, 4 mg/d

Raclopride is an original synthesis from former Astra in Södertälje

Farde et al, 1986

The human genome  About 20.500 protein-encoding genes Clamp et al, PNAS, 2007

 A third of them are expressed in brain  Accumulated portfolio of industry • Binds to 473 proteins (Drews et al, 1996)

Examples of original radioligand development at Karolinska Institutet 1982-2010 Monkeys • 160 radioligands examined after radiolabelling Man • 38 radioligands examined • 16-18 validated and suitable for applied studies world wide

The global toolbox targets about 50 brain proteins

•D2-dopamine • [11C]raclopride (1985) • [11C]FLB457 (1997) •D1-dopamine • [11C]SCH23390 (1985) • [11C]NNC112 (1995) •Dopamine transporter • [11C]PE2I (2004) •Serotonin transporter • [11C]MADAM (2003) •Serotonin 5HT2a • [11C]MDL100907 (1997) •Benzodiazepine • [11C]Flumazenil (1986) • [18F]Flumazenil (2006) •Norepinephrine transporter • [18F]FD2MeNER (2006) •Serotonin 5HT1b • [11C]AZ10419369 (2008) •Amyloid Plaque • [11C]AZD2184 (2008) • [18F]AZD4694 (2009)

11C]raclopride binding to D2-dopamine receptors

Control Scanditronix PC384-15B 384 detectors 8-11 mm FWHM

Haloperidol, 4 mg/d

Farde et al, 1986

High Resolution Research Tomograph (2008) • Dedicated for neuroimaging • 120.000 detector elements • Fully operational Jan 2008 • Highest resolution in series (2.0 mm) • New reconstruction principle (PSF) provides improved resolution (1.5 mm)

Andrea Varrone

18 september 2014

17

High resolution imaging of [11C]flumazenil binding to benzodiazepine receptors

GABAA receptors in vivo and in post-mortem human brain [11C]flumazenil HR

[11C]flumazenil HRRT

[18F]flumazenil Autoradiography

Monoaminergic innervation of the human brain

• The shared organization may reflect phylogenesis • Implicated in fundamental functions, i.e adaptation to environment, emotions etc • Functions that are impaired in major psychiatric disorders

From Fuchs and Flügge, Dialogues Clin Neurosci. 2004;6:171-183.

PET imaging of brainstem nuclei:

**: p

Suggest Documents